ArticleClinical Medicine Insights. Oncology2024

Combined Positive Score and Cisplatin Sensitivity Are Prognostic Factors for Response to Nivolumab Therapy for Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck.

Hiroaki Iijima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.